Zimbabwe has rejected a substantial American health deal valued at 367 million US dollars (£272m) over five years because of the United States' demand for confidential information.
This rejection came to light following a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa felt the deal was "lopsided".
An official representative later stated that the US was requesting health data for scientific study and commercial purposes but refused to guarantee the resulting advantages from any future vaccines.
"We must now begin the challenging and unfortunate process of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for more negotiations to find a agreement suitable to all parties so the country's critical HIV treatment initiative can be sustained.
Broader Background
This development comes after a similar situation in Kenya, where a high court halted a related deal with the US following legal challenges were filed about the security of Kenyans' health data.
Since resuming office recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government agreements to boost transparency and responsibility.
As per reports, Sixteen African countries have to date agreed to these new agreements, representing more than $18.3bn in new funding.
Details of the Declined Deal
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, with no equivalent guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," his statement read.
"Effectively, our country would supply the basic resources for medical research without any assurance that the resulting innovations would be available to our citizens should a future pandemic arise."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting frameworks previously established via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with potential global health emergencies.
"This mechanism is intended to ensure that when a nation provides its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," he added.
"We welcome further discussions with our American counterparts on how subsequent co-operation might be arranged in a way that respects the sovereignty and dignity of each country."
Medical Community Reaction
A leading public health body expressed it understood the government's concerns, but suggested that talks need to persist since a large portion of the country's HIV programmes depended on external financing.
"Where technical issues exist, such as those involving information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," the group commented.
The halted deal underscores the continuing debate between receiving much-needed international aid and protecting local interests in an ever more interconnected world.